Viewing Study NCT02745769


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-25 @ 8:23 PM
Study NCT ID: NCT02745769
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2016-04-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module